Saturday, 31 October 2026European Markets

ACOMO, BONDUELLE, Another 1 Companies Have A High Dividend Yield And Return On Equity In The Consumer Defensive Sector.

Loading stream...

(vianews) - acomo (acomo.as) is among this list of stock assets with the highest dividend rate and return on equity on the consumer defensive sector.

financial asset price forward dividend yield return on equity
acomo (acomo.as) €17.40 6.9% 11.27%
bonduelle (bon.pa) €10.80 2.29% 1.08%
l''oreal (or.pa) €439.30 1.54% 21.72%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. acomo (acomo.as)

6.9% forward dividend yield and 11.27% return on equity

acomo n.v., together with its subsidiaries, engages in sourcing, trading, processing, packaging, and distributing conventional and organic food ingredients and solutions for the food and beverage industry worldwide. it operates through five segments: spices and nuts, edible seeds, organic ingredients, tea, and food solutions. the spices and nuts segment provides tropical products, including pepper, nutmeg, desiccated coconut, shelled and unshelled nuts, dried fruits, dehydrated vegetables, herbs, rice crackers, and snack products. its edible seeds segment trades, processes, and distributes edible seeds, such as poppy, sesame, pumpkin, and flax, as well as sunflower seeds comprising in-kernel and shelled for the snack and retail industries; birdseeds for wildlife; and edible seeds to bakery, spice, and confectionery industries. the organic ingredients segment provides a range of organic food products and ingredients in various categories, including cocoa, coffee, fruit and vegetables, edible seeds, nuts and dried fruits, oils, and premium juice products. its tea segment trades, processes, and distributes through warehouses and blending facilities; and monitors and analyzes market development, and shares insight to customers to meet traditional consumer preferences, which include novel appetites for specialty tea. the food solutions segment produces and supplies culinary and functional ingredients, plant-based solutions, wet and dry blends, and spice mixes to food companies; and provides product development, manufacturing, packaging, distribution, and inventory management services. the company was formerly known as amsterdam commodities n.v. and changed its name to acomo n.v. in june 2022. acomo n.v. was founded in 1908 and is based in rotterdam, the netherlands.

earnings per share

as for profitability, acomo has a trailing twelve months eps of €1.55.

pe ratio

acomo has a trailing twelve months price to earnings ratio of 11.23. meaning, the purchaser of the share is investing €11.23 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.27%.

revenue growth

year-on-year quarterly revenue growth declined by 6.2%, now sitting on 1.38b for the twelve trailing months.

more news about acomo.

2. bonduelle (bon.pa)

2.29% forward dividend yield and 1.08% return on equity

bonduelle sca produces, processes, and sells vegetables and fruits in europe and internationally. the company offers canned, frozen, fresh cut, and ready to eat vegetables, as well as packaged and prepared ready to eat vegetable salads; and salad bowls, meals, ready-to-mix salads, value-added vegetables, etc. it provides its products under the bonduelle, cassegrain, del monte, arctic gardens, globus, and ready pac foods brands, as well as private labels. the company was founded in 1853 and is headquartered in renescure, france.

earnings per share

as for profitability, bonduelle has a trailing twelve months eps of €0.27.

pe ratio

bonduelle has a trailing twelve months price to earnings ratio of 40. meaning, the purchaser of the share is investing €40 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 1.08%.

more news about bonduelle.

3. l''oreal (or.pa)

1.54% forward dividend yield and 21.72% return on equity

l'oréal s.a., through its subsidiaries, manufactures and sells cosmetic products for women and men worldwide. the company operates through four divisions: consumer products, l'oréal luxe, professional products, and active cosmetics. it offers shampoos, hair care products, shower gels, skincare products, cleansers, hair colorants, deodorants, sun care products, make-up, perfumes, etc. the company provides its products under the l'oréal paris, garnier, maybelline new york, nyx professional makeup, stylenanda, essie, dark & lovely, mixa, magic mask, niley, lancôme, yves saint laurent, armani, kiehl's since 1851, halena rubinstein, biotherm, shu uemura, it cosmetics, ralph lauren fragrance, urban decay, mugler, valentino, viktor&rolf, azzaro, prada, cacharel, maison margela fragrance, diesel, yue sai, atelier colonge, carita, takami, l'oréal professionnel paris, kérastase, redken, matrix, pureology, pulp riot, la roche-posay, vichy, cerave, skinceuticals, decléor, and skinbetter science brands. it sells its products through distribution channels, such as hair salons, local stores, e-commerce, travel retail, mass market retail, department store perfumeries, pharmacies, drug stores, medi-spas, and branded retail. l'oréal s.a. was founded in 1909 and is headquartered in clichy, france.

earnings per share

as for profitability, l''oreal has a trailing twelve months eps of €10.88.

pe ratio

l''oreal has a trailing twelve months price to earnings ratio of 40.38. meaning, the purchaser of the share is investing €40.38 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.72%.

more news about l''oreal.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com